OTC Artificial Tears Market Expected to Reach $6.4 Billion by 2028 | Current Trends and Industry Analysis

OTC artificial tears market generated $4,379 million in 2020, and is projected to reach $6,399.43 million by 2028, growing at a CAGR of 4.94% from 2021 to 2028. The artificial tears are the lubricant eye drops, which are used for the treatment of dryness and irritation mostly caused due to deficiency of tear production. These artificial tears are formulated to initiate natural tears and treats various eye disorders such as allergy, infection and protection from UV and blue light. It was also used for moisturizing the contact lens.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

BAUSCH & LOMB, SANTEN PHARMACEUTICAL, URSAPHARM, SIMILASAN CORPORATION, .ALLERGAN, OCUSOFT, LUMECARE, ABBOTT LABORATORIES, JOHNSON & JOHNSON, NOVARTIS AG (ALCON)

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/11708

Depending on container type, the market is categorized into plastic single dose container, plastic multi-dose container and spray. The plastic multi-dose container spearheaded the market in 2020, which is attributed to the fact that the majority of the drugs administered for the treatment of dry eye syndrome and prevent the penetration of germs even after repeated administration. The plastic single dose container segment is further classified into preservative free system and preserved system. Further, the spray segment is further bifurcated into preservative free system and preserved system. By formulation, the market is segregated into a preservative based and non-preservative based. The non-preservative based segment forms are expected to lead the market during the study period, due to low risk of adverse reaction and increase in adoption of preservative free eye drops.

By application, the market is studied across dry eye syndrome, allergies, infections, UV & blue light protection, contact lens moisture retention and others. The dry eye syndrome is expected to exhibit the highest growth throughout the forecast period, owing to rise in the prevalence of dry eye syndrome and increase in the geriatric population.

On the basis of distribution channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The Drug Store & Retail Pharmacies segment led the market in 2020, and is expected to continue this trend throughout the forecast period, due to increase in prevalence of chronic eye ailments such as dry eye syndrome, allergies and infection and rise in development of the healthcare sector.

The COVID-19 outbreak is anticipated to have a moderate impact on the growth of the global OTC artificial tears market. The coronavirus pandemic has severely affected various industries across the globe. The implementation of lockdown by governments has to lead to the disruption of the supply chain. However, the facility for non-essential medical products will improve the prospects of the market during the pandemic.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/11708

North America accounted for a majority of the global OTC artificial tears market share in 2020 and is anticipated remain dominant during the forecast period. This is attributed to owing to rise in prevalence of the geriatric population, increase in prevalence dry eye, and initiatives taken by government for eye health. Furthermore, rise in awareness about the prevention and treatment of eye disease, and increase in demand for advanced healthcare facilities are contributing toward the growth of the market. Moreover, upsurge in R&D activities in healthcare sector to develop novel OTC artificial tears and presence of major players operating in the region fuel the growth of the market. Asia-Pacific is anticipated to witness lucrative growth, owing to rise in prevalence allergies and dry eye and rise in awareness regarding OTC artificial tears.

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com